Psyence Biomedical Ltd. (PBM) Profit After Tax (2023 - 2025)

Psyence Biomedical's Profit After Tax history runs 3 years deep, the most recent figure standing at -$753254.0 for Q3 2025.

• In Q3 2025, Profit After Tax fell 632.44% year-over-year to -$753254.0; the TTM figure through Sep 2025 stood at -$3.5 million (changed N/A YoY), while the FY2026 annual figure was -$6.9 million, down 785.56% from the prior year.
• Profit After Tax for Q3 2025 stood at -$753254.0, down from $141473.0 in the prior quarter.
• The five-year high for Profit After Tax was $306906.0 in Q3 2023, with the low at -$3.2 million in Q1 2023.
• The 3-year median for Profit After Tax is -$305890.5 (2024), against an average of -$877819.5.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax slumped 53.9% in 2024, then plunged 632.44% in 2025.
• Psyence Biomedical's Profit After Tax stood at $306906.0 in 2023, then plunged by 53.9% to $141473.0 in 2024, then slumped by 632.44% to -$753254.0 in 2025.
• Business Quant data shows PBM's Profit After Tax at -$753254.0 in Q3 2025, $141473.0 in Q3 2024, and $306906.0 in Q3 2023.